Research programme: small interfering RNA therapeutics - Sciwind Biosciences/SynerK
Alternative Names: Research programme: siRNA therapeutics - Sciwind Biosciences/SynerKLatest Information Update: 06 Oct 2022
At a glance
- Originator Sciwind Biosciences
- Class Drug conjugates; Hepatoprotectants; Small interfering RNA
- Mechanism of Action RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Liver disorders; Metabolic disorders